摘要:
A battery cell in an implantable medical device is presented. The battery cell includes an anode, a cathode, an insulator therebetween, and an electrolyte. The cathode includes silver vanadium oxide and fluorinated carbon (CFx). The CFx includes fluorine at greater than or equal to 61 percentage (%) by weight.
摘要:
A battery cell in an implantable medical device is presented. The battery cell includes an anode, a cathode, an insulator therebetween, and an electrolyte. The cathode includes silver vanadium oxide and fluorinated carbon (CFx). The CFx includes fluorine at greater than or equal to 61 percentage (%) by weight.
摘要:
The present teachings include an electrochemical cell including an anode, a cathode, an electrolyte, a separator disposed between the cathode and anode, and a housing containing the anode, cathode, electrolyte, and separator. The separator can include a first sheet consisting essentially of a single layer material and a second sheet distinct from the first sheet. The second sheet can include an inner microporous layer laminated between two more outer layers. In some cells, the inner layer can have a transition temperature between a porous configuration and a substantially non-porous configuration that is between about 80 degrees C. and 150 degrees C., and in which the two more outer layers maintain their structural integrity to at least about 10 degrees C. greater than the first layer transition temperature.
摘要:
An organic additive to an electrolyte for a battery cell in an implantable medical device is presented. At least one organic additive is selected from a group comprising one of lithium salicylate, hydroxyphthalic anhydride, a hydroxybenzoic acid, salicylate ester, salicylamide, and salicylanilide.
摘要:
An organic additive to an electrolyte for a battery cell in an implant able medical device is presented. At least one organic additive is selected from a group comprising one of lithium salivate, hydroxyphthalic anhydride, a hydroxybenzoic acid, salivate ester, salicylamide, and salicylanilide.
摘要:
According to one aspect of the present invention, an electrochemical cell is provided. The electrochemical cell includes a housing, an anode and a cathode within the housing, and an electrolytic solution within the housing and contacting the anode and the cathode. The electrolytic solution includes a solute and a solvent. The solute includes at least one of tetrafluoroborate and an organic cation.
摘要:
The present teachings include an electrochemical cell including an anode, a cathode, an electrolyte, a separator disposed between the cathode and anode, and a housing containing the anode, cathode, electrolyte, and separator. The separator can include a first sheet consisting essentially of a single layer material and a second sheet distinct from the first sheet. The second sheet can include an inner microporous layer laminated between two more outer layers. In some cells, the inner layer can have a transition temperature between a porous configuration and a substantially non-porous configuration that is between about 80 degrees C. and 150 degrees C., and in which the two more outer layers maintain their structural integrity to at least about 10 degrees C. greater than the first layer transition temperature.
摘要:
The invention provides heat-treated silver vanadium oxide for use in the cathodes of electrochemical cells, particularly in implantable medical devices. The heat-treated silver vanadium oxide is capable of being pressed into a pellet having a pressed pellet density of about 3.10 g/cm.sup.3 to about 3.45 g/cm.sup.3 when about 2 grams of the heat-treated silver vanadium oxide are uniaxially pressed into a pellet using a 1.6 cm diameter cylindrical die with a 7500 pound force applied for 5 seconds.
摘要翻译:本发明提供了用于电化学电池的阴极中的热处理的银钒氧化物,特别是在可植入的医疗装置中。 热处理的银钒氧化物能够压制成压片的密度为约3.10g / cm 3至约3.45g / cm 3的丸粒,当将约2克经热处理的银钒氧化物单轴压制成颗粒时 使用1.6厘米直径的圆柱模具,施加7500磅的力5秒。
摘要:
This invention relates to a molecular modification reagent consisting of an inorganic oxide substrate having surface oxygens bonded to silylcobalt tetracarbonyl groups. This reagent is functionalized to form new compounds useful e.g., in semi-conductor industry, sensor industry, chromatography and modified support industry, and in the isolation of biologically active molecules.
摘要:
This present invention provides a method for forming C-SVO without the need for flowing O.sub.2 during its synthesis. A method of forming silver vanadium oxide in accordance with the present invention includes combining AgO with a vanadium-containing compound to form a mixture; and exposing the mixture to a sufficient temperature for a time effective to form silver vanadium oxide. A method of forming the silver vanadium oxide for use as a cathode material is disclosed.